Seok-Jun Hong1, Boris C Bernhardt1, Benoit Caldairou1, Jeffery A Hall1, Marie C Guiot1, Dewi Schrader1, Neda Bernasconi1, Andrea Bernasconi2. 1. From the Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital (S.-J.H., B.C.B., B.C., J.A.H., M.C.G., N.B., A.B.), Neuroimaging of Epilepsy Laboratory, McConnell Brain Imaging Centre (S.-J.H., B.C.B., B.C., D.S., N.B., A.B.), and Department of Pathology (M.C.G.), McGill University, Montreal, Canada. 2. From the Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital (S.-J.H., B.C.B., B.C., J.A.H., M.C.G., N.B., A.B.), Neuroimaging of Epilepsy Laboratory, McConnell Brain Imaging Centre (S.-J.H., B.C.B., B.C., D.S., N.B., A.B.), and Department of Pathology (M.C.G.), McGill University, Montreal, Canada. andrea@bic.mni.mcgill.ca.
Abstract
OBJECTIVE: To characterize in vivo MRI signatures of focal cortical dysplasia (FCD) type IIA and type IIB through combined analysis of morphology, intensity, microstructure, and function. METHODS: We carried out a multimodal 3T MRI profiling of 33 histologically proven FCD type IIA (9) and IIB (24) lesions. A multisurface approach operating on manual consensus labels systematically sampled intracortical and subcortical lesional features. Geodesic distance mapping quantified the same features in the lesion perimeter. Logistic regression assessed the relationship between MRI and histology, while supervised pattern learning was used for individualized subtype prediction. RESULTS: FCD type IIB was characterized by abnormal morphology, intensity, diffusivity, and function across all surfaces, while type IIA lesions presented only with increased fluid-attenuated inversion recovery signal and reduced diffusion anisotropy close to the gray-white matter interface. Similar to lesional patterns, perilesional anomalies were more marked in type IIB extending up to 16 mm. Structural MRI markers correlated with categorical histologic characteristics. A profile-based classifier predicted FCD subtypes with equal sensitivity of 85%, while maintaining a high specificity of 94% against healthy and disease controls. CONCLUSIONS: Image processing applied to widely available MRI contrasts has the ability to dissociate FCD subtypes at a mesoscopic level. Integrating in vivo staging of pathologic traits with automated lesion detection is likely to provide an objective definition of lesional boundary and assist emerging approaches, such as minimally invasive thermal ablation, which do not supply tissue specimen.
OBJECTIVE: To characterize in vivo MRI signatures of focal cortical dysplasia (FCD) type IIA and type IIB through combined analysis of morphology, intensity, microstructure, and function. METHODS: We carried out a multimodal 3T MRI profiling of 33 histologically proven FCD type IIA (9) and IIB (24) lesions. A multisurface approach operating on manual consensus labels systematically sampled intracortical and subcortical lesional features. Geodesic distance mapping quantified the same features in the lesion perimeter. Logistic regression assessed the relationship between MRI and histology, while supervised pattern learning was used for individualized subtype prediction. RESULTS:FCD type IIB was characterized by abnormal morphology, intensity, diffusivity, and function across all surfaces, while type IIA lesions presented only with increased fluid-attenuated inversion recovery signal and reduced diffusion anisotropy close to the gray-white matter interface. Similar to lesional patterns, perilesional anomalies were more marked in type IIB extending up to 16 mm. Structural MRI markers correlated with categorical histologic characteristics. A profile-based classifier predicted FCD subtypes with equal sensitivity of 85%, while maintaining a high specificity of 94% against healthy and disease controls. CONCLUSIONS: Image processing applied to widely available MRI contrasts has the ability to dissociate FCD subtypes at a mesoscopic level. Integrating in vivo staging of pathologic traits with automated lesion detection is likely to provide an objective definition of lesional boundary and assist emerging approaches, such as minimally invasive thermal ablation, which do not supply tissue specimen.
Authors: Ingmar Blümcke; Maria Thom; Eleonora Aronica; Dawna D Armstrong; Harry V Vinters; Andre Palmini; Thomas S Jacques; Giuliano Avanzini; A James Barkovich; Giorgio Battaglia; Albert Becker; Carlos Cepeda; Fernando Cendes; Nadia Colombo; Peter Crino; J Helen Cross; Olivier Delalande; François Dubeau; John Duncan; Renzo Guerrini; Philippe Kahane; Gary Mathern; Imad Najm; Ciğdem Ozkara; Charles Raybaud; Alfonso Represa; Steven N Roper; Noriko Salamon; Andreas Schulze-Bonhage; Laura Tassi; Annamaria Vezzani; Roberto Spreafico Journal: Epilepsia Date: 2010-11-10 Impact factor: 5.864
Authors: Richard L Nolan; Nicholas Brandmeir; Eric S Tucker; John L Magruder; Mark R Lee; Gang Chen; James W Lewis Journal: Neurosurg Focus Date: 2020-02-01 Impact factor: 4.047
Authors: Seok-Jun Hong; Sofie L Valk; Adriana Di Martino; Michael P Milham; Boris C Bernhardt Journal: Cereb Cortex Date: 2018-10-01 Impact factor: 5.357
Authors: Boris C Bernhardt; Fatemeh Fadaie; Min Liu; Benoit Caldairou; Shi Gu; Elizabeth Jefferies; Jonathan Smallwood; Danielle S Bassett; Andrea Bernasconi; Neda Bernasconi Journal: Neurology Date: 2019-04-19 Impact factor: 9.910
Authors: Ravnoor Singh Gill; Hyo-Min Lee; Benoit Caldairou; Seok-Jun Hong; Carmen Barba; Francesco Deleo; Ludovico D'Incerti; Vanessa Cristina Mendes Coelho; Matteo Lenge; Mira Semmelroch; Dewi Victoria Schrader; Fabrice Bartolomei; Maxime Guye; Andreas Schulze-Bonhage; Horst Urbach; Kyoo Ho Cho; Fernando Cendes; Renzo Guerrini; Graeme Jackson; R Edward Hogan; Neda Bernasconi; Andrea Bernasconi Journal: Neurology Date: 2021-09-14 Impact factor: 9.910
Authors: Sophie Adler; Sara Lorio; Thomas S Jacques; Barbora Benova; Roxana Gunny; J Helen Cross; Torsten Baldeweg; David W Carmichael Journal: Neuroimage Clin Date: 2017-04-20 Impact factor: 4.881